Chemerin as a Driver of Cardiovascular Diseases: New Perspectives and Future Directions
In recent years, the immune system has emerged as a key player in the development of atherosclerosis, heart failure, venous thromboembolism, and systemic hypertension. Obesity and related cardiovascular diseases (CVDs) remain the leading global cause of death. Adipokines—hormones produced by adipose...
Saved in:
| Main Authors: | Anna M. Imiela, Jan Stępnicki, Patrycja Sandra Zawadzka, Angelika Bursa, Piotr Pruszczyk |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/6/1481 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structural Basis for Chemerin Recognition and Signaling Through Its Receptors
by: Yezhou Liu, et al.
Published: (2024-10-01) -
Evaluation of Salivary Chemerin and Visfatin in Relation to Periodontitis and Obesity
by: Farah Razak Abood, et al.
Published: (2025-04-01) -
Active Forms of Chemerin Are Elevated in Human and Mouse Ovarian Carcinoma
by: Lei Zhao, et al.
Published: (2025-04-01) -
The Role of Chemerin in Neutrophil Activation and Diseases of the Lung
by: Patrick Arndt
Published: (2025-05-01) -
CHEMERIN AS A POTENTIAL REGULATOR OF MITOCHONDRIAL QUALITY CONTROL IN OBESE PATIENTS
by: M. A. Vulf, et al.
Published: (2021-10-01)